Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: picture (143), illustration (14), diagram (76)

Finance, Investment and Cash Committee ToR October 2025

Description: Finance, Investment and Cash Committee Terms of Reference Date Issued: Review Date: Document Type: 7 October 2025 October
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Finance-Investment-and-Cash-Committee-ToR-October-2025.pdf

Ipilimumab-Nivolumab Ver1

Description: Chemotherapy Protocol MESOTHELIOMA IPILIMUMAB-NIVOLUMAB Regimen • Mesothelioma – Ipilimumab-Nivolumab Indication • Nivolumab in combination with ipilimumab is indicated for the first-line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/Ipilimumab-Nivolumab-Ver1.pdf

Papers Trust Board - 10 March 2026

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 10/03/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-10-March-2026.pdf

AmB-LISOCEL-Cyclophosphamide (300)-Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AmB – LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) Ambulatory Regimen This regimen is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LISOCEL-Cyclophosphamide-300-Fludarabine-30.pdf

Lisocel – Cyclophosphamide (300) – Fludarabine (30) Ver1

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) This regimen will only be available
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lisocel-–-Cyclophosphamide-300-–-Fludarabine-30.pdf

covid19_advice_for_parents_when_child_unwell_or_injured_poster

Description: Advice for parents during coronavirus Whilst coronavirus is infectious to children it is rarely serious. If your chi
Url: /Images/News/covid19-advice-for-parents-when-child-unwell-or-injured-poster.pdf

Press release: Liver expert says alcohol withdrawal symptoms 'to blame' for workplace anxiety

Description: A liver expert has said people who feel anxious about returning to work after binge drinking over the festive season may
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/December/Press-release-Liver-expert-says-alcohol-withdrawal-symptoms-'to-blame'-for-workplace-anxiety.aspx

Press release: Southampton expert says home genetic testing kits "shouldn't be used for healthcare decisions"

Description: A leading doctor based at Southampton's university hospitals has warned against the use of home genetic testing kits and called for
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/October/Press-release-Southampton-expert-says-home-genetic-testing-kits-shouldnt-be-used-for-healthcare-decisions.aspx

Press release: Surgeon calls for 'radical culture change' towards drinking water

Description: A leading surgeon has said a "radical culture change" towards drinking water is required to help the country stay hydrated during
Url: /AboutTheTrust/Newsandpublications/Latestnews/2018/July-2018/Press-release-Surgeon-calls-for-radical-culture-change-towards-drinking-water.aspx

Prof Ratko Djukanovic, respiratory and critical care theme lead

Description: NIHR Southampton Biomedical Research Centre Auto Generated Title A respiratory consultant and researcher with a focus on asthma and chronic obst
Url: /ClinicalResearchinSouthampton/Our-people/Respiratory-research-people/Prof-Ratko-Djukanovic-respiratory-and-critical-care-theme-lead.aspx

31 to 40 of 156

Previous … 2 3 4 5 6 … Next